Study of Lithium Biodistribution and Nephrotoxicity in Skin Melanoma Mice Model: The First Step towards Implementing Lithium Neutron Capture Therapy
Life · 14.02.2023 · 13 (2) · 518
DOI: 10.3390/life13020518 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 14.02.2023. Verfasst von Iuliia Taskaeva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Ultrastructural Research, Research Institute of Clinical and Experimental Lymphology-Branch of the Institute of Cytology and Genetics, …. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Academy of Sciences, Research Institute of Clinical and Experimental Lymphology (Novosibirsk), the Budker Institute of Nuclear Physics (Novosibirsk).
Abstract (Originalsprache)
Boron neutron capture therapy (BNCT) is one of the promising treatment methods for malignant melanoma. The main issue of this technology is the insufficient selectivity of 10B accumulation in tumor cells. As a result of the neutron absorption by boron, an 84% energy release occurred within the cell by the nuclear reaction 10B (n, α)7Li, which lead to tumor cell death. The use of lithium instead of boron brings a new unique opportunity—local 100% energy release—since all products of the 6Li (n, α)3H reaction have high linear energy transfer characteristics. The aim of this study was to determine the concentrations of Li in the tumor, skin, blood, brain and kidney in experimental animals with B16 melanoma and to analyze the potential Li toxicity after lithium carbonate administration at single doses of 300 and 400 mg/kg. Lithium carbonate was chosen since there is a long-term experience of its use in clinical practice for the treatment of psychiatric disorders. The inductively coupled plasma atomic emission spectrometry was used to evaluate Li concentrations in tissue samples. The accumulation efficiency of Li in the tumor was the highest at a time point of 30 min (22.4 µg/g; at a dose of 400 mg/kg). Despite the high lithium accumulation in the kidneys, the pathological changes in kidney tissues were not found. Thus, lithium may actually be used for the Li-NCT development and future studies can be conducted using 6Li and following irradiation of tumor cells using the schemes of lithium administration tested in this work.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Ultrastructural Research, Research Institute of Clinical and Experimental Lymphology-Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, 630060 Novosibirsk…
- Budker Institute of Nuclear Physics, 630090 Novosibirsk, Russia.
ORCID-Profile: Anna Kasatova
Förderung
- Russian Academy of Sciences
- Research Institute of Clinical and Experimental Lymphology (Novosibirsk)
- the Budker Institute of Nuclear Physics (Novosibirsk)
Zitieren
APA
Taskaeva, I., Kasatova, A., Surodin, D., Bgatova, N., & Taskaev, S. (2023). Study of Lithium Biodistribution and Nephrotoxicity in Skin Melanoma Mice Model: The First Step towards Implementing Lithium Neutron Capture Therapy. Life, 13(2), 518. https://doi.org/10.3390/life13020518
Vancouver
Taskaeva I, Kasatova A, Surodin D, Bgatova N, Taskaev S. Study of Lithium Biodistribution and Nephrotoxicity in Skin Melanoma Mice Model: The First Step towards Implementing Lithium Neutron Capture Therapy. Life. 2023;13(2):518. doi:10.3390/life13020518
BibTeX
@article{Taskaeva2023,
author = {Taskaeva, Iuliia and Kasatova, Anna and Surodin, Dmitry and Bgatova, Nataliya and Taskaev, Sergey},
title = {Study of Lithium Biodistribution and Nephrotoxicity in Skin Melanoma Mice Model: The First Step towards Implementing Lithium Neutron Capture Therapy},
journal = {Life},
year = {2023},
volume = {13},
number = {2},
pages = {518},
doi = {10.3390/life13020518}
}
EUVIMED